From: CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
Variable | PFS | OS | ||
---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
Age | 1.035 (1.005–1.067) | 0.021 | 1.060 (1.026–1.094) | <0.001 |
Stage | 4.149 (1.762–9.772) | 0.001 | 2.450 (0.930–6.453) | 0.070 |
CDH22 hypermethylation | 4.289 (1.507–12.209) | 0.006 | 2.498 (0.821–7.601) | 0.107 |